Investigating how radiation therapy affects tumor immunity and cancer treatment outcomes
Washington University (WU) ROBIN Center: MicroEnvironment and Tumor Effects Of Radiotherapy (METEOR)
This study is looking at how radiation therapy affects the immune system's ability to fight tumors, with the goal of finding better ways to treat advanced cancers, and it’s designed for patients who want to understand how their treatment might work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10912695 on NIH RePORTER |
What this research studies
This research explores the effects of radiation therapy on tumor immunity, focusing on how it modifies the tumor microenvironment and influences immune responses. By examining the balance between immune-stimulating and immune-suppressing effects of radiation, the study aims to understand how these interactions can impact the effectiveness of cancer treatments. Patients may benefit from insights gained through a dynamic Molecular Characterization Trial that integrates various research projects and resources, ultimately aiming to improve treatment strategies for advanced cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with advanced cancers who are undergoing or have undergone radiation therapy.
Not a fit: Patients with early-stage cancers or those not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by enhancing the immune response against tumors.
How similar studies have performed: Previous research has shown promising results in understanding the immune effects of radiation therapy, indicating that this approach has potential for significant advancements in cancer treatment.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Schwarz, Julie Kristina — Washington University
- Study coordinator: Schwarz, Julie Kristina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.